Susan Rhodes

Susan Rhodes

Auto-generated profile, based on publicly available information

Susan Rhodes

Paul O'Gorman Leukaemia Research Centre, College of Medical, Veterinary & Life Sciences, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2014 in Blood
Verified
Journal Article
Open access
PDF file
PGPaolo Gallipoli
Paolo Gallipoli
ACAmy Cook
Amy Cook
SRSusan Rhodes
Susan Rhodes
LHLisa Hopcroft
Lisa Hopcroft
HWHelen Wheadon
Helen Wheadon
THTessa L. Holyoake
Tessa L. Holyoake
Key Points: The JAK2/STAT5 pathway is a relevant therapeutic target in CML SPCs. Targeting the JAK2/STAT5 pathway by nilotinib and RUX in combination leads to enhanced eradication of primitive CML stem cells.